However, despite previous reports on the potential advantage posed by GLP1-based multi-agonists in the management of obesity and metabolic disease, as recently exemplified by the dramatic body weight-lowering actions of the GLP1/GIP dual agonist, tirzepatide 47 , to our knowledge, no study has addressed to date the pharmacological characterization of GLP1-based unimolecular multi-agonists for management of reproductive and metabolic alterations of PCOS, using suitable preclinical models, as pre-requisite for their application in clinics
If GH-related effects such as improved sleep quality, recovery speed, or body composition changes plateau before the cycle ends, that is an early signal of receptor saturation
Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats
About this article Cite this article Ferreira, F.H.d.C., Pinto, L.R., Oliveira, B.A
Safe to take together
Free Radical Biology and Medicine , 67, 396-407